News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,607 Results
Type
Article (45965)
Company Profile (291)
Press Release (702337)
Multimedia
Podcasts (91)
Webinars (22)
Section
Business (209096)
Career Advice (2122)
Deals (36136)
Drug Delivery (130)
Drug Development (83016)
Employer Resources (175)
FDA (17106)
Job Trends (15291)
News (354276)
Policy (33759)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2769)
Accelerated approval (42)
Adcomms (27)
Allergies (163)
Alliances (51317)
ALS (201)
Alzheimer's disease (1797)
Antibody-drug conjugate (ADC) (373)
Approvals (17408)
Artificial intelligence (620)
Autoimmune disease (234)
Automation (52)
Bankruptcy (364)
Best Places to Work (11892)
BIOSECURE Act (20)
Biosimilars (205)
Biotechnology (197)
Bladder cancer (179)
Brain cancer (64)
Breast cancer (697)
Cancer (5398)
Cardiovascular disease (449)
Career advice (1793)
Career pathing (41)
CAR-T (309)
CDC (54)
Celiac Disease (2)
Cell therapy (825)
Cervical cancer (42)
Clinical research (71318)
Collaboration (1951)
Company closure (4)
Compensation (1272)
Complete response letters (73)
COVID-19 (2811)
CRISPR (103)
C-suite (993)
Cystic fibrosis (151)
Data (7116)
Decentralized trials (3)
Denatured (31)
Depression (157)
Dermatology (57)
Diabetes (555)
Diagnostics (6994)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (306)
Drug pricing (204)
Drug shortages (30)
Duchenne muscular dystrophy (267)
Earnings (92009)
Editorial (61)
Employer branding (21)
Employer resources (154)
Events (121176)
Executive appointments (1051)
FDA (20561)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1663)
Gene editing (221)
Generative AI (54)
Gene therapy (678)
GLP-1 (1029)
Government (4853)
Grass and pollen (6)
Guidances (397)
Healthcare (19572)
HIV (76)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (284)
Immuno-oncology (84)
Indications (157)
Infectious disease (3127)
Inflammatory bowel disease (203)
Inflation Reduction Act (15)
Influenza (130)
Intellectual property (273)
Interviews (328)
IPO (16818)
IRA (52)
Job creations (3715)
Job search strategy (1495)
JPM (59)
Kidney cancer (19)
Labor market (93)
Layoffs (563)
Leadership (36)
Legal (8142)
Liver cancer (100)
Longevity (29)
Lung cancer (724)
Lymphoma (413)
Machine learning (54)
Management (60)
Manufacturing (939)
MASH (178)
Medical device (14441)
Medtech (14522)
Mergers & acquisitions (20479)
Metabolic disorders (1422)
mRNA (183)
Multiple sclerosis (177)
NASH (17)
Neurodegenerative disease (393)
Neuropsychiatric disorders (99)
Neuroscience (3230)
Neurotech (2)
NextGen: Class of 2026 (6796)
Non-profit (4671)
Now hiring (73)
Obesity (668)
Opinion (288)
Ovarian cancer (187)
Pain (235)
Pancreatic cancer (257)
Parkinson's disease (348)
Partnered (33)
Patents (555)
Patient recruitment (599)
Peanut (62)
People (60448)
Pharmaceutical (60)
Pharmacy benefit managers (34)
Phase 1 (22298)
Phase 2 (31406)
Phase 3 (23333)
Pipeline (7168)
Policy (314)
Postmarket research (2611)
Preclinical (9555)
Press Release (69)
Prostate cancer (276)
Psychedelics (50)
Radiopharmaceuticals (306)
Rare diseases (1023)
Real estate (6107)
Recruiting (71)
Regulatory (25730)
Reports (54)
Research institute (2551)
Resumes & cover letters (370)
Rett syndrome (32)
RNA editing (17)
RSV (86)
Schizophrenia (165)
Series A (277)
Series B (208)
Service/supplier (12)
Sickle cell disease (106)
Special edition (24)
Spinal muscular atrophy (176)
Sponsored (45)
Startups (3749)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (86)
The Weekly (58)
Vaccines (1093)
Venture capital (102)
Weight loss (426)
Women's health (110)
Worklife (19)
Date
Last 7 days (642)
Last 30 days (2485)
Last 365 days (30380)
2026 (8109)
2025 (30686)
2024 (35822)
2023 (40826)
2022 (52012)
2021 (56650)
2020 (55216)
2019 (48014)
2018 (36165)
2017 (33153)
2016 (32644)
2015 (38754)
2014 (32492)
2013 (27726)
2012 (29879)
2011 (30505)
2010 (28457)
Location
Africa (784)
Alabama (91)
Alaska (7)
Arizona (336)
Arkansas (14)
Asia (41191)
Australia (6732)
California (12360)
Canada (3522)
China (1252)
Colorado (531)
Connecticut (540)
Delaware (368)
Europe (90349)
Florida (1858)
Georgia (406)
Hawaii (3)
Idaho (66)
Illinois (972)
India (83)
Indiana (562)
Iowa (23)
Japan (491)
Kansas (132)
Kentucky (46)
Louisiana (38)
Maine (73)
Maryland (1504)
Massachusetts (8891)
Michigan (347)
Minnesota (692)
Mississippi (7)
Missouri (149)
Montana (36)
Nebraska (29)
Nevada (138)
New Hampshire (85)
New Jersey (3288)
New Mexico (31)
New York (3281)
North Carolina (1575)
North Dakota (9)
Northern California (6103)
Ohio (373)
Oklahoma (23)
Oregon (43)
Pennsylvania (2500)
Puerto Rico (26)
Rhode Island (50)
South America (1163)
South Carolina (76)
South Dakota (1)
Southern California (4853)
Tennessee (202)
Texas (1945)
United States (43952)
Utah (373)
Vermont (1)
Virginia (297)
Washington D.C. (81)
Washington State (1008)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
748,607 Results for "neuron systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oryon Cell Therapies Emerges From Stealth Focusing on Autologous Neuron Replacement Therapies for Parkinson’s Disease and Other Neurodegenerative Disorders
March 23, 2026
·
5 min read
Press Releases
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
February 9, 2026
·
8 min read
Press Releases
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
March 17, 2026
·
6 min read
Press Releases
Nature Translational Psychiatry Study Reveals Distinct Functional Neuronal Signatures in Patient-Derived Brain Organoids with Itay&Beyond’s Neurotech Platform
March 24, 2026
·
1 min read
Press Releases
Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer’s Disease Pathology Following Porosome Reconstitution Therapy
November 18, 2025
·
3 min read
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve motor function and mobility in patients.
March 23, 2026
·
2 min read
·
Tristan Manalac
Pharm Country
Stimulation of Sensory Neurons Increases Antibody Responses
One of the major functions of the immune system is to – through antibodies – fight infections. New findings from The Feinstein Institutes for Medical Research bioelectronic medicine scientists show that neurons that help sense pain and prevent illness, called sensory neurons, play an important role in regulating the production of antibodies.
May 30, 2024
·
4 min read
Press Releases
Quanta System Inc.: Strengthening the U.S. Presence of Italian Laser Technology
March 1, 2026
·
4 min read
Press Releases
BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson’s Disease
November 3, 2025
·
2 min read
Press Releases
Verist Inc. Announces Relationship with Basil Systems to Strengthen Life Sciences Offering
February 26, 2026
·
3 min read
1 of 74,861
Next
